Viewing Study NCT04083833


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2026-03-02 @ 3:59 PM
Study NCT ID: NCT04083833
Status: COMPLETED
Last Update Posted: 2019-09-10
First Post: 2019-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects
Sponsor: Wex Pharmaceuticals Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None TQT Study View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TQT TTX Halneuron cardiac safety View